Table 2.
Basic information of participants in the second batch verification queue
| Healthy controls | Omicron | P | |
|---|---|---|---|
| N | 20 | 20 | |
| Age | 54.00 (36.75–58.75) | 53.00 (46.00–62.00) | 0.580 |
| WBC, 109/L | 6.64 (5.35–9.27) | 5.80 (4.62–7.85) | 0.229 |
| NEU % | 53.88 (44.30–61.44) | 92.66 (73.34–105.28) | < 0.001 |
| LYM % | 29.37 (26.30–34.81) | 16.71 (13.34–28.89) | < 0.001 |
| MONO % | 6.98 (5.34–8.29) | 12.33 (10.61–14.60) | < 0.001 |
| EOS % | 1.45 (0.88–3.38) | 1.65 (0.93–2.10) | 0.839 |
| BASO % | 0.86 (0.38–1.13) | 0.17 (0.10–0.22) | < 0.001 |
| NEU, 109/L | 5.00 (3.67–6.05) | 5.28 (2.65–5.53) | 0.655 |
| LYM, 109/L | 2.40 (1.80–3.15) | 1.50 (0.80–2.30) | 0.004 |
| MONO, 109/L | 0.44 (0.26–0.65) | 0.42 (0.37–0.66) | 0.960 |
| EOS, 109/L | 0.22 (0.16–0.37) | 0.15 (0.08–0.21) | 0.004 |
| BASO, 109/L | 0.02 (0.01–0.03) | 0.03 (0.02–0.03) | 0.194 |
| PT, S | 12.45 (11.73–13.40) | 14.00 (12.85–14.58) | 0.003 |
| INR | 0.75 (0.60–0.90) | 0.90 (0.80–1.18) | 0.060 |
| PTTA, % | 97.00 (92.43–109.00) | 83.20 (76.25–94.10) | < 0.001 |
| FIB, g/L | 2.90 (2.53–3.45) | 4.74 (3.53–5.52) | < 0.001 |
| APTT, S | 35.70 (31.50–40.15) | 41.40 (31.85–47.18) | 0.048 |
| TT, S | 16.15 (15.23–18.78) | 16.55 (15.20–18.33) | 0.745 |
| D-Dimer, μg/L | 297.00 (211.00–364.75) | 510.00 (439.50–603.50) | < 0.001 |
| CRP, mg/dL | 2.75 (1.65–4.13) | 8.50 (5.80–10.40) | < 0.001 |
| SAA, mg/L | 5.50 (3.10–8.38) | 35.75 (30.48–44.88) | < 0.001 |
| PCT, ng/mL | 0.02 (0.01–0.05) | 0.09 (0.06–0.15) | < 0.001 |
WBC White blood cell, NEU Neutrophil, LYM Lymphocyte, MONO Monocyte, EOS Eosinophils, BASO Basophil, PT Prothrombin time, INR International normalized ratio, PTTA Prothrombin activity, FIB Fibrinogen, APTT Activated partial thromboplastin time, TT Thrombin, DD D-Dimer, CRP C-reactive protein, SAA Serumamyloid A, PCT Procalcitonin